Siedlerstraße 7 | 68623 Lampertheim, Germany

info@zamann-pharma.com

Novocure reported that unauthorized access to certain information systems in mid-August exposed records linked to more than 1,400 U.S. patients. The company confirmed that its medical treatment devices were not accessed and all systems remain operational. Nevertheless, the incident highlights